Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
32.98B
Market cap32.98B
Price-Earnings ratio
13.04
Price-Earnings ratio13.04
Dividend yield
2.62%
Dividend yield2.62%
Average volume
7.36M
Average volume7.36M
High today
$79.06
High today$79.06
Low today
$77.20
Low today$77.20
Open price
$77.79
Open price$77.79
Volume
17.09M
Volume17.09M
52 Week high
$161.77
52 Week high$161.77
52 Week low
$72.38
52 Week low$72.38

Stock Snapshot

With a market cap of 32.98B, Zoetis(ZTS) trades at $78.70. The stock has a price-to-earnings ratio of 13.04 and currently yields dividends of 2.62%.

During the trading session on 2026-06-20, Zoetis(ZTS) shares reached a daily high of $79.06 and a low of $77.20. At a current price of $78.70, the stock is +1.9% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 17.09M, compared to an average daily volume of 7.36M.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $161.77 and a low of $72.38.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $161.77 and a low of $72.38.

ZTS News

Simply Wall St 2d
Does Class Action Scrutiny of Companion Animal Disclosures Change The Bull Case For Zoetis?

In recent months, multiple law firms have launched or reminded investors of securities class action lawsuits against Zoetis, alleging the company misled the mar...

Does Class Action Scrutiny of Companion Animal Disclosures Change The Bull Case For Zoetis?
Nasdaq 2d
Zoetis Surpasses Market Returns: Some Facts Worth Knowing

Zoetis (ZTS) ended the recent trading session at $168.82, demonstrating a +1.5% change from the preceding day's closing price. The stock outperformed the S&P 50...

Zoetis Surpasses Market Returns: Some Facts Worth Knowing
TipRanks 4d
Zoetis Kept at Hold as Competitive Pressures Mount and Innovation Lags; Price Target Maintained at $108

Zoetis, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Ryskin from Bank of America Securities maintained a Hold ra...

Analyst ratings

58%

of 19 ratings
Buy
57.9%
Hold
42.1%
Sell
0%

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.